Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia

被引：8
作者：
Hashimoto, K. [1 ]
Sudo, T.
Hirano, M.
Motomura, H.
Tagawa, K.
Nashiro, S.
Uemura, K.
Yoshimoto, S.
机构：
[1] Natl Hosp Org, Hizen Psychiat Ctr, Saga 8420192, Japan
[2] Yahata Kosei Hosp, Kitakyushu, Fukuoka 8070846, Japan
[3] Mitate Hosp, Fukuoka 8260041, Japan
[4] Okinawa Chuo Hosp, Okinawa 9042143, Japan
[5] Kouno Hosp, Saga 8400806, Japan
[6] Ureshino Onsen Hosp, Saga 8400301, Japan
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 87卷 / 1-3期
关键词：
D O I：
10.1016/j.schres.2006.03.048
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：332 / 333
页数：2
相关论文
共 6 条
  • [1] ZOTEPINE IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS WITH PREVAILINGLY NEGATIVE SYMPTOMS - A DOUBLE-BLIND TRIAL VS HALOPERIDOL
    BARNAS, C
    STUPPACK, CH
    MILLER, C
    HARING, C
    SPERNERUNTERWEGER, B
    FLEISCHHACKER, WW
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 7 (01) : 23 - 27
  • [2] GRESCH PJ, 1995, J NEUROCHEM, V65, P111
  • [3] INADA T, 1996, EVALUATION DIAGNOSIS, P25
  • [4] Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: Results from a double-blind study
    MeyerLindenberg, A
    Gruppe, H
    Bauer, U
    Lis, S
    Krieger, S
    Gallhofer, B
    [J]. PHARMACOPSYCHIATRY, 1997, 30 (02) : 35 - 42
  • [5] A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo
    Rowley, HL
    Needham, PL
    Kilpatrick, IC
    Heal, DJ
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 361 (02) : 187 - 192
  • [6] Pharmacological profile of neuroleptics at human monoamine transporters
    Tatsumi, M
    Jansen, K
    Blakely, RD
    Richelson, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 368 (2-3) : 277 - 283
1